MedTrace Logo

Role of Metabolic Enzymes in Non-Melanoma Skin Cancer

NCT02244749 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2022-11-01

No results posted yet for this study

Summary

The researcher can proved that certain compounds play an important role in the prevention of skin cancer. Researcher can use specific compounds, which classified as metabolic enzymes, and lower concentrations and complete absent in skin cancer cells. Researcher can biopsies of normal skin and precancerous or cancerous lesions, and can compare the concentrations of these compounds to determine the difference between the two areas. The result can lead to further understanding of skin cancers and pre-cancers. Because skin cancers and pre-cancers are so common, any knowledge would be very useful for many people in the future and may be used for development of future treatments or prevention strategies.

Conditions

Interventions

OTHER

skin specimen

skin specimen

Sponsors & Collaborators

  • Chao Family Comprehensive Cancer Center

    collaborator OTHER

  • Beckman Laser Institute University of California Irvine

    collaborator OTHER

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Kristen Kelly, MD · Beckman Laser Institute, UCI

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02244749 on ClinicalTrials.gov